Literature DB >> 10672902

Phosphospecific antibodies reveal focal adhesion kinase activation loop phosphorylation in nascent and mature focal adhesions and requirement for the autophosphorylation site.

P J Ruest1, S Roy, E Shi, R L Mernaugh, S K Hanks.   

Abstract

Focal adhesion kinase (FAK) is a key signaling molecule regulating cellular responses to integrin-mediated adhesion. Integrin engagement promotes FAK phosphorylation at multiple sites to achieve full FAK activation. Phosphorylation of FAK Tyr-397 creates a binding site for Src-family kinases, and phosphorylation of FAK Tyr-576/Tyr-577 in the kinase domain activation loop enhances catalytic activity. Using novel phosphospecific antibody reagents, we show that FAK activation loop phosphorylation is significantly elevated in cells expressing activated Src and is an early event following cell adhesion to fibronectin. In both cases, this regulation is largely dependent on Tyr-397. We also show that the FAK activation loop tyrosines are required for maximal Tyr-397 phosphorylation. Finally, immunostaining analyses revealed that tyrosine-phosphorylated forms of FAK are present in both newly forming and mature focal adhesions. Our findings support a model for reciprocal activation of FAK and Src-family kinases and suggest that FAK/Src signaling may occur during both focal adhesion assembly and turnover.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10672902

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  28 in total

1.  FAK potentiates Rac1 activation and localization to matrix adhesion sites: a role for betaPIX.

Authors:  Fumin Chang; Christopher A Lemmon; Dongeun Park; Lewis H Romer
Journal:  Mol Biol Cell       Date:  2006-11-08       Impact factor: 4.138

Review 2.  Focal adhesion: a focal point in current cell biology and molecular medicine.

Authors:  Chuanyue Wu
Journal:  Cell Adh Migr       Date:  2007-01-27       Impact factor: 3.405

3.  A FAK/Src chimera with gain-of-function properties promotes formation of large peripheral adhesions associated with dynamic actin assembly.

Authors:  Priscila M F Siesser; Leslie M Meenderink; Larisa Ryzhova; Kristin E Michael; David W Dumbauld; Andrés J García; Irina Kaverina; Steven K Hanks
Journal:  Cell Motil Cytoskeleton       Date:  2008-01

4.  SRC catalytic but not scaffolding function is needed for integrin-regulated tyrosine phosphorylation, cell migration, and cell spreading.

Authors:  Leslie A Cary; Richard A Klinghoffer; Christoph Sachsenmaier; Jonathan A Cooper
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

Review 5.  The on-off relationship of Rho and Rac during integrin-mediated adhesion and cell migration.

Authors:  Campbell D Lawson; Keith Burridge
Journal:  Small GTPases       Date:  2014-03-07

6.  Toxoplasma gondii disrupts β1 integrin signaling and focal adhesion formation during monocyte hypermotility.

Authors:  Joshua H Cook; Norikiyo Ueno; Melissa B Lodoen
Journal:  J Biol Chem       Date:  2018-01-02       Impact factor: 5.157

7.  Mechanisms of CAS substrate domain tyrosine phosphorylation by FAK and Src.

Authors:  P J Ruest; N Y Shin; T R Polte; X Zhang; S K Hanks
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

8.  v-Crk activates the phosphoinositide 3-kinase/AKT pathway by utilizing focal adhesion kinase and H-Ras.

Authors:  Tsuyoshi Akagi; Kazutaka Murata; Tomoyuki Shishido; Hidesaburo Hanafusa
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

9.  Sympathetic activation causes focal adhesion signaling alteration in early compensated volume overload attributable to isolated mitral regurgitation in the dog.

Authors:  Abdelkarim Sabri; Khadija Rafiq; Rachid Seqqat; Mikhail A Kolpakov; Ray Dillon; Louis J Dell'italia
Journal:  Circ Res       Date:  2008-03-20       Impact factor: 17.367

10.  Quantification of focal adhesion kinase activation loop phosphorylation as a biomarker of Src activity.

Authors:  Eugene Ciccimaro; Steven K Hanks; Ian A Blair
Journal:  Mol Pharmacol       Date:  2008-12-19       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.